{"id":232416,"date":"2025-07-02T12:06:55","date_gmt":"2025-07-02T16:06:55","guid":{"rendered":"https:\/\/today.uconn.edu\/?p=232416"},"modified":"2025-07-02T15:25:16","modified_gmt":"2025-07-02T19:25:16","slug":"increasing-contingency-management-incentives-will-help-more-patients-recover-from-addiction","status":"publish","type":"post","link":"https:\/\/today.uconn.edu\/2025\/07\/increasing-contingency-management-incentives-will-help-more-patients-recover-from-addiction\/","title":{"rendered":"Increasing Contingency Management Incentives Will Help More Patients Recover from Addiction"},"content":{"rendered":"<p>Early recovery from addiction to opioids and stimulants is physically and mentally demanding, and involves a long road to recovery.<\/p>\n<p>\u201cDuring the early stages of addiction recovery there is typically not much that is positive for patients,\u201d says behavioral health counselor Carla J. Rash, Ph.D. of UConn School of Medicine. \u201cBut Contingency Management is an effective, behavioral tool bringing some early-on positivity to a patient\u2019s addiction recovery treatment plan until the positive benefits of their medication and body\u2019s natural recovery kicks-in.\u201d<\/p>\n<p>While nationally under-used and under-resourced, the behavioral therapy known as Contingency Management (CM) has been shown to be the most effective, first-line addiction recovery tool for stimulants like cocaine and methamphetamine. For substance abuse with opioids, such as heroin and prescription painkillers, CM can be used effectively as an adjunct to first-line medication treatments.<\/p>\n<p>Rash adds, \u201cEssentially, by offering incentives through Contingency Management vouchers and prizes, we are saying to them that if they are doing the hard work of recovery, we want to encourage and positively reward those efforts. I have seen CM have such an enormous impact on so many patients\u2019 lives.\u201d<\/p>\n<figure id=\"attachment_232423\" aria-describedby=\"caption-attachment-232423\" style=\"width: 414px\" class=\"wp-caption alignleft\"><img decoding=\"async\" class=\"wp-image-232423  img-responsive lazyload\" data-src=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2025\/07\/Addiction-Recovery-AdobeStock_767260030-1024x671.jpeg\" alt=\"Addiction recovery graphic (AdobeStock image). \" width=\"414\" height=\"272\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 414px; --smush-placeholder-aspect-ratio: 414\/272;\" \/><figcaption id=\"caption-attachment-232423\" class=\"wp-caption-text\"><em>\u00a0(AdobeStock image).<\/em><\/figcaption><\/figure>\n<p>Reported for the first time, in <a href=\"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/article-abstract\/2836114\">JAMA Psychiatry<\/a> on July 2, lead author Rash of UConn and co-researchers at the University of Vermont School of Medicine and Washington State University Medicine examined the published literature on 112 CM protocols reinforcing reductions in stimulant and\/or opioid use. As a result of the study review, the researchers were able to pinpoint the most effective and evidence-based incentive dosage levels (i.e., magnitude) to use during CM care, adjusting it for present-day inflation levels.<\/p>\n<p>The collaborative research team recommends the use of a weekly CM incentive standard of sufficient magnitude of $128 per week for vouchers or $55 per week for prizes over 12 weeks or longer to effectively reduce stimulant and\/or opioid use.<\/p>\n<p>For example, these estimates would equate to about $1,536 in CM incentive costs for voucher awards and $660 for prize awards over a typical 12-week protocol. Interestingly, the study authors share the context that in comparison this cost of using evidence-based magnitude CM incentive levels would be comparable or be less-costly weekly for example than first-line opioid use disorder treatments such as methadone ($126\/week), buprenorphine ($115\/week), and injectable naltrexone ($271\/week). Plus, CM is typically a time-limited therapy.<\/p>\n<p>\u201cOur new study findings are important because it highlights the right \u2018dosage\u2019 or magnitude of Contingency Management,\u201d says Rash.<\/p>\n<p>To put the research team\u2019s new recommended incentive dollar amounts in perspective, the federal oversight agency of The Substance Abuse and Mental Health Services Administration (SAMHSA) only this year increased its longstanding funding coverage of CM incentives from $75 per patient, per year to $750 per patient, per year.<\/p>\n<p>\u201cOur new JAMA Psychiatry study shows that the current federal CM incentive amounts are still too low to support evidence-based protocols. An effective CM dosage is essential for policy makers and health care providers alike to consider when implementing this intervention,\u201d stresses Rash.<\/p>\n<p>Rash adds, \u201cStrong guardrails are necessary for the use of CM. Clinicians and researchers should not make up their own protocols for CM as ineffective protocols may be damaging.\u201d<\/p>\n<h3><strong>Career Mission to Bring Effective Contingency Management to More People<\/strong><\/h3>\n<p>\u201cTo patients and families, Contingency Management is an effective tool for you or your loved one and can truly help bridge a person to success during the early stages of addiction recovery,\u201d says Rash. \u201cWe are working hard to bring greater access to this most effective treatment to more people.\u201d<\/p>\n<figure id=\"attachment_232422\" aria-describedby=\"caption-attachment-232422\" style=\"width: 231px\" class=\"wp-caption alignleft\"><img decoding=\"async\" class=\"size-medium wp-image-232422 img-responsive lazyload\" data-src=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2025\/07\/rash-carla-20190318-kwallace-0533-crop-231x300.jpg\" alt=\"Lead JAMA Psychiatry study author and Contingency Management expert Carla Rash, Ph.D. of UConn School of Medicine (UConn Health photo\/Kristin Wallace).\" width=\"231\" height=\"300\" data-srcset=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2025\/07\/rash-carla-20190318-kwallace-0533-crop-231x300.jpg 231w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2025\/07\/rash-carla-20190318-kwallace-0533-crop-788x1024.jpg 788w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2025\/07\/rash-carla-20190318-kwallace-0533-crop-768x999.jpg 768w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2025\/07\/rash-carla-20190318-kwallace-0533-crop-1181x1536.jpg 1181w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2025\/07\/rash-carla-20190318-kwallace-0533-crop-323x420.jpg 323w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2025\/07\/rash-carla-20190318-kwallace-0533-crop-511x665.jpg 511w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2025\/07\/rash-carla-20190318-kwallace-0533-crop.jpg 1339w\" data-sizes=\"(max-width: 231px) 100vw, 231px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 231px; --smush-placeholder-aspect-ratio: 231\/300;\" \/><figcaption id=\"caption-attachment-232422\" class=\"wp-caption-text\"><em>Lead JAMA Psychiatry study author and Contingency Management expert Carla Rash, Ph.D. of UConn School of Medicine (UConn Health photo\/Kristin Wallace).<\/em><\/figcaption><\/figure>\n<p>In 2007 Rash first started as a post-doctoral fellow at the School of Medicine.<\/p>\n<p>\u201cI got into Contingency Management for addiction recovery when I was a grad student. I was interested in learning all about addiction therapies and wanting to work on what really was the most effective option,\u201d says Rash.<\/p>\n<p>At the time it was early-on in the Contingency Management field, but Rash was hooked on learning absolutely everything about it.<\/p>\n<p>\u201cI wanted to learn more about CM, make it more accessible, and even more effective,\u201d she says. Advancing CM quickly became her career goal.<\/p>\n<p>Rash quickly got her first CM-focused grant application funded by the National Institutes of Health and chose to stay at UConn to grow her CM research and career.<\/p>\n<p>Fast forward to today, nearly two decades later, her CM research remains NIH-funded. She serves UConn as an associate professor in the Department of Medicine at the UConn School of Medicine and the Pat and Jim Calhoun Cardiology Center\u2019s Behavioral Cardiovascular Prevention Division at UConn Health.<\/p>\n<p>Rash\u2019s ongoing research tries to better understand the most effective way to motivate treatment initiation and minimize relapse in addictions, especially the use of Contingency Management interventions. Her work is also funded by the Robert Wood Johnson Foundation (RWJF) and SAMHSA.<\/p>\n<p>\u201cWe have come a long way in getting CM out to the clinical realm,\u201d says Rash who was honored to work with her mentor, the late Dr. Nancy Petry, on the first and largest national clinical CM program Petry started in 2011 for the Veterans Administration. The extraordinarily successful program is still ongoing. Also, a few states have started their own CM programs with the biggest in California.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>JAMA Psychiatry study recommends nationwide Contingency Management care guardrails with data-driven, evidence-based reward amounts to ensure effective and better care outcomes<\/p>\n","protected":false},"author":98,"featured_media":232418,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","wds_primary_category":0,"wds_primary_series":0,"wds_primary_attribution":0,"footnotes":""},"categories":[1715,2460,2231,2648,2076,1868,2235,179],"tags":[],"magazine-issues":[],"coauthors":[1873],"class_list":["post-232416","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-community-impact","category-faculty","category-health-well-being","category-blue-research","category-research","category-meds","category-today-homepage","category-uconn-health"],"pp_statuses_selecting_workflow":false,"pp_workflow_action":"current","pp_status_selection":"publish","acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-26 02:22:08","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts\/232416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/users\/98"}],"replies":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/comments?post=232416"}],"version-history":[{"count":9,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts\/232416\/revisions"}],"predecessor-version":[{"id":232477,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts\/232416\/revisions\/232477"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/media\/232418"}],"wp:attachment":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/media?parent=232416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/categories?post=232416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/tags?post=232416"},{"taxonomy":"magazine-issue","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/magazine-issues?post=232416"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/coauthors?post=232416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}